Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
IS-free Treg HaploHCT
for
Stem Cell Transplant Complications, Graft Vs Host Disease,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18 - 70+
Code: NCT04678401
Phase 1, Recruiting
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, Pittsburgh PA, Houston TX, Newport Beach CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05372640
Phase 1, Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Boston MA, East Providence RI, Bloomfield CT,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase 2, Phase 3, Recruiting
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Location: Boston MA, New York NY, Columbus OH, Indianapolis IN,
Sponsor: Aria CV, Inc
Sex: All
Age: 18+
Code: NCT04555161
Recruiting
Lurbinectedin in FET-Fused Tumors
for
Ewing Sarcoma, Desmoplastic Small Round Cell Tumor,
Location: Boston MA, New York NY, Philadelphia PA, Ann Arbor MI,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 10+
Code: NCT05918640
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Tolerability of 532 nm Laser Treatment of Port Wine Stains
for
Port-Wine Stain
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT05841628
Recruiting
Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy
for
Cytokine Release Syndrome
Location: Boston MA, Pittsburgh PA, Durham NC, Augusta GA,
Sponsor: CytoAgents, Inc.
Sex: All
Age: 18+
Code: NCT05905328
Phase 1, Phase 2, Recruiting
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS
for
AML, Adult, MDS
Location: Boston MA, New York NY, Cleveland OH, Columbus OH,
Sponsor: Stelexis BioSciences
Sex: All
Age: 18+
Code: NCT06533761
Phase 1, Recruiting
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, York PA, Bethesda MD, Barrie, Hampton VA,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06588478
Phase 2, Recruiting
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
for
Phenylketonuria (PKU)
Location: Boston MA, Pittsburgh PA, Indianapolis IN, Chicago IL,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 0+
Code: NCT05813678
Recruiting
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, New York NY, Canton OH, Detroit MI,